Skip Page Links

  • Skip to navigation
  • Skip to content
Ulster University logo Return to Ulster University homepage
  • Global students – Resources for Ulster University International Students
  • Staff Links – Resources for Ulster University staff
  • Student Guide - The Student Guide to Ulster
  • Portal - for Ulster University
  • Find staff & Departments – search and browse Ulster’s staff directory
  • News – for Ulster University
  • Events – for Ulster University
  • Home - Ulster University website homepage
  • Study at Ulster University

    Study options

    • Study in Northern Ireland
    • Undergraduate study options
    • Postgraduate study options
    • Postgraduate Research/ PhD
    • Short courses and CPD
    • Part-time Undergraduate study options
    • Part-time study options
    • eLearning study at Ulster University

    Courses

    • Search for courses
    • A to Z 2023/24
    • A to Z 2022/23

    More information

    • Entrance requirements
    • Equivalence of qualifications
    • Your rights and obligations
    • International students
    • Further education students
    • Associate students
  • Campus Life at Ulster University

    Campus Life

    • Campuses
    • Accommodation - Residential Services
    • Sport Services
    • Students' Union UUSU
    • All Ulster University Events

    Support

    • Student Guide
    • Student Wellbeing
    • Digital Services
    • Library

    Careers and Opportunities

    • Employability and Careers
    • Go Global
    • Science Shop
    • Student Enterprise
  • Research & Impact

    Research & Impact

    • Our research
    • Collaboration and Innovation
    • Work with us
    • Our Research Topics
    • Our Research Teams

    PhD/Research degrees

    • Funded & Self Funded PhDs
    • Postgraduate Research Programmes
    • How to apply for PhD Research
    • Funding for Phd's
    • Contact the Doctoral College

    More information

    • PURE - research portal
    • REF 2021 (Research Excellence Framework)
    • Policies and Procedures
  • Business themed areas of Ulster University

    Work with Us

    • Recruit top talent
    • Business School student placements
    • Scholarships, sponsorships and corporate giving
    • Upskill courses by Sector

    Business Engagement

    • Build a course
    • Executive Education Courses
    • Apprenticeship Hub
    • Business leader Peer Mentoring
    • Postgraduate short courses

    Research Expertise

    • Work with us
    • Funding opportunities
    • Innovation Ulster Ltd
    • Case studies
    • Meet the team

    Further Information

    • Market information
    • Hire one of our venues
  • Graduates of Ulster University
  • Home - Go to homepage
  • Study Options at Ulster University
  • Find a course at Ulster University
  • Campus Life
  • Research & Impact at Ulster University
  • Business at Ulster University
  • Graduates - find out about Alumni and Supporters at Ulster University
  • Global Students – become part of our global community at Ulster University

  • Student Guide
  • Staff Links – Resources for Ulster University staff
  • Find staff & Departments – search and browse Ulster’s staff directory
  • Portal – customise and access your online services

  •   Twitter account for Ulster University
  •   Facebook account for Ulster University
  •   YouTube account for Ulster University
Ulster University
  • Search
  • Link for Ulster University
  • Link for News
  • Link for 2016
  • Link for April 2016
7 April 2016

Ulster University research shows epilepsy drug may not increase birth defects risks

New research from Ulster University has shown a drug used to treat epilepsy may not increase the risk of birth defects such as cleft lip, cleft palate or clubfoot as previously thought.

More than 500,000 people in the UK have epilepsy, 20,000 in Northern Ireland and 40,000 in Ireland. Maintaining effective treatment during pregnancy is important because seizures may cause harm to the fetus.

The epilepsy drug Lamotrigine can typically be used on its own or in combination with other medications to control seizures. It is also prescribed to prevent mood swings for those with bipolar disorder.

The new research by Ulster University into this specific drug estimates that the maximum additional risk of cleft lip or cleft palate would be one in every 550 babies exposed to it, a substantial reduction on previous studies.

The study is part of a programme of research on antiepileptic drugs by Ulster University researchers. It examined 10 million births over 16 years where 226,806 babies had birth defects. It found 147 babies within that group who were exposed to the epilepsy drug Lamotrigine during the first trimester of pregnancy had non-genetic birth defects.

In the general population, one in every 700 babies is born with cleft lip or cleft palate, or 0.14 percent. Nearly one in 1,000 babies is born with club foot.

The study was funded by Glaxo Smith Kline and was published today in Neurology, the medical journal of the American Academy of Neurology.

Ulster University's Professor Helen Dolk said: "An initial US study of this drug showed an increase for cleft lip or cleft palate. A number of other studies, including our previous study, have not shown an increase in those conditions, although our previous study did show an increased risk of clubfoot.

"This new study has a much larger population size – more than double the size of our previous study.

"We cannot exclude a small risk of cleft lip or cleft palate, but we estimate the excess risk among babies exposed to the drug, if any, to be less than one in every 550 babies. We did not find any further evidence of a clubfoot risk.

"Since excess risks of cleft lip or palate have been reported for a variety of antiepileptic drugs, we recommend that for all mothers with epilepsy, whatever their drug exposure, special attention be given to examining the baby for cleft palate.

"It is important that women with epilepsy and other women taking antiepileptics are given preconception care to consider which antiepileptics have the best benefit versus risk profile for them in pregnancy as any change of medication needs to occur before pregnancy. Some antiepileptics, most notably valproic acid, should be avoided in pregnancy."

 Professor Dolk is now recommending an additional study to give specific information on the effect of high Lamotrigine dosage on birth defects.


Share Article:
  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn

Related news

  1. Wed 10 Aug 2022

    CEBE celebrates its Innovation in Placement Winners

  2. Mon 08 Aug 2022

    Colleagues and Friends invited to support the Stethoscopes and Arclights for Students Appeal

  3. Fri 05 Aug 2022

    Ulster University Elks secure Randox sponsorship for USA championship

Elsewhere on Ulster

Faculty of Arts, Humanities & Social Sciences

Faculty of Computing, Engineering and the Built Environment

Faculty of Life and Health Sciences

Ulster University Business School- Faculty

Courses & Research

  • Search for courses
  • Undergraduate courses at Ulster University
  • Postgraduate courses at Ulster University
  • Part-time courses at Ulster University
  • Short courses & CPD at Ulster University
  • Study online at Ulster University
  • Research & Impact
  • Doctoral College
  • PURE Research Portal

Campus locations

  • Belfast campus
  • Coleraine campus
  • Jordanstown campus
  • Magee campus
  • London and Birmingham
  • Qatar

Campus facilities

  • Residential Services / Accommodation
  • Sports Services - Memberships and Facilities
  • Library Services and resources supporting learning, teaching and research at the University

About The University

  • About Ulster University
  • Contact Details
  • Job opportunities
  • Key calendar dates
  • Faculties at Ulster University
  • News - Ulster University
  • Events - Ulster University

Other sites

  • Alumni & Supporters
  • Confucius Institute
  • Get advice from Employability and Careers
  • Finance Department
  • Flexible Education
  • Digital Services - computing, digital and media services
  • People & Culture
  • Student Wellbeing
  • Sustainability

Ulster University social

@StudyAtUlster Follow us on Twitter @UlsterUni Follow us on Twitter
Study At Facebook UU Facebook
Study At Youtube UU Youtube
Ulster Uni Instagram

Footer Links

  • Privacy Policy
  • Accessibility Statements
  • Copyright
  • Freedom of Information
  • Modern Slavery Statement

© Copyright Ulster University 2022.

Ulster University is registered with the Charity Commission for Northern Ireland (NIC100166).